NSE: ORTINLAB - Ortin Laboratories Limited

Rentabilité sur six mois: +15.94%
Rendement en dividendes: 0.00%

Calendrier des promotions Ortin Laboratories Limited

fr.porti.ru30.0030.0027.0027.0024.0024.0021.0021.0018.0018.0015.0015.00mai '23mai '23juin '23juin '23juill. '23juill. '23août '23août '23sept. '23sept. '23oct. '23oct. '23nov. '23nov. '23déc. '23déc. '2320242024févr. '24févr. '24mars '24mars '24avr. '24avr. '24mai '24mai '24juin '24juin '24juill. '24juill. '24août '24août '24sept. '24sept. '24oct. '24oct. '24
Télécharger au format SVG
Télécharger au format PNG
Télécharger au format CSV

À propos de l'entreprise Ortin Laboratories Limited

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti-diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides; and anti-anginal and cardio vascular, and antifungal products.

plus de détails
Its formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium and iron preparations, anti-arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti-retroviral products. In addition, the company offers active pharmaceutical ingredient (API) intermediates, including anti retro viral, anti-diabetics, analgesics and antipyretics, anti-biotics, antifungal, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company provides services in the areas of process development, process and product characterization, analytical research and development, and assay development; and diagnostic services comprising development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. The company was formerly known as Ortin Laboratories Limited and changed its name to Ortin Global Limited in June 2024. Ortin Global Limited was incorporated in 1986 and is headquartered in Hyderabad, India.

ISIN INE749B01020
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Сайт https://www.ortinlabsindia.com
Цена ао 20.87
Changement de prix par jour: 0% (20.87)
Changement de prix par semaine: -1.32% (21.15)
Changement de prix par mois: -2.75% (21.46)
Changement de prix sur 3 mois: +5.24% (19.83)
Changement de prix sur six mois: +15.94% (18)
Changement de prix par an: +5.67% (19.75)
Evolution du prix sur 3 ans: -40.54% (35.1)
Evolution du prix sur 5 ans: +206.41% (6.8112)
Evolution des prix depuis le début de l'année: +5.24% (19.83)

Sous-estimation

Nom Signification Grade
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Efficacité

Nom Signification Grade
ROA, % 0 0
ROE, % 0 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA 0 10
Total: 10

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % -96.31 0
Rentabilité Ebitda, % -91.11 0
Rentabilité EPS, % 0 0
Total: 0

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Sanka Murali Krishna Murthy CEO & MD 1959 (66 années)
Mr. Sanka Srinivasa Kumar CFO & Whole Time Director 1965 (60 années)

Adresse: India, Hyderabad, D. No. 1-8-B4 F3 HIG - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.ortinlabsindia.com